Atlas Trials

Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity

Clinical trial NCT02183883 · COMPLETED

Trial details

NCT number
NCT02183883
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2016-12-16
Primary completion
2023-03-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.